In the BioHarmony Drug Report Database

"Preview" Icon

Lomitapide

Juxtapid, Lojuxta (lomitapide) is a small molecule pharmaceutical. Lomitapide was first approved as Juxtapid on 2012-12-21. It is used to treat hypercholesterolemia in the USA. It has been approved in Europe to treat hypercholesterolemia. Juxtapid’s patents are valid until 2027-08-19 (FDA).

 

Trade Name

 

Lojuxta
 

Common Name

 

lomitapide
 

ChEMBL ID

 

CHEMBL354541
 

Indication

 

hypercholesterolemia
 

Drug Class

 

Microsomal triglyceride transfer protein (MTP) inhibitors

Image (chem structure or protein)

Lomitapide structure rendering